Magnetic resonance elastography for evaluation of renal parenchyma in chronic kidney disease: a pilot study.
Jun Hee Han, Jhii-Hyun Ahn, Jae-Seok Kim
https://pubmed.ncbi.nlm.nih.gov/32367323Actively Recruiting
Led by Shengjing Hospital · Updated on 2026-02-10
200
Participants Needed
1
Research Sites
N/A
Total Duration
Chronic Kidney Disease (CKD) affects about 10% of people worldwide and can lead to serious outcomes like death or the need for kidney replacement therapy. Kidney fibrosis, or scarring, is a key factor in how CKD progresses. This research focuses on using multifrequency Magnetic Resonance Elastography (MRE), a noninvasive imaging method that measures tissue stiffness, to better understand kidney fibrosis, especially in early CKD stages when kidney function may still appear normal. Participants include adults with CKD and healthy volunteers without kidney disease. Both groups will undergo the same detailed MRI scans, including MRE and other advanced imaging techniques, to assess kidney tissue properties. CKD patients will have their MRI within 7 days of a kidney biopsy and will also have blood tests and blood pressure measured. Healthy volunteers serve as a comparison group to establish baseline imaging values. During the study, participants will undergo various imaging sessions and blood tests to track kidney health and fibrosis. Researchers will measure changes in kidney filtration rate over 24 months as the main outcome. This study will also explore how combined MRI techniques might predict CKD progression. Participation includes follow-up and monitoring over time to collect these important kidney health data.
CONDITIONS
Multifrequency MRE in Evaluation of Chronic Kidney Diseases
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Within 7 days of renal biopsy for CKD patients; timing for healthy volunteers as scheduled
Participants undergo comprehensive MRI scans including Magnetic Resonance Elastography and other functional MRI techniques to evaluate kidney and liver characteristics. For CKD patients, MRI is performed within 7 days of their renal biopsy, and blood tests along with blood pressure measurements are collected.
1 to 2 visits depending on participant group and biopsy timing
Duration - 24 months
Participants are monitored over 24 months to assess the annual rate of decline in kidney function (eGFR) through follow-up evaluations.
Follow-up visits as scheduled during the 24-month period
Total: 1 location
1
Shengjing Hospital of China Medical University
Shenyang, Liaoning, China, 110004
Actively Recruiting
Y
yu shi, MD
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Jun Hee Han, Jhii-Hyun Ahn, Jae-Seok Kim
https://pubmed.ncbi.nlm.nih.gov/32367323Markus Grossmann, Heiko Tzschätzsch, Sophia T Lang...
https://pubmed.ncbi.nlm.nih.gov/31287390